The impact of the opioid antagonist naloxone on experimentally induced craving in nicotine-dependent individuals
Gorde:
Krause, D., et al., The impact of the opioid antagonist naloxone on experimentally induced craving in nicotine-dependent individuals. European Addiction Research, vol. 24, n. 5, 2018, p. 255-265.
Erref.
548004
Kokapena:
SIIS R.1142
Hitz-gakoak:
Drogodependencias, Tabaco, Ansiedad, Abstinencia, Opiáceos, Naltrexona, Efectos, Tratamiento médico, Evaluación, Resultados, Estudio comparativo
Drogodependencias, Tabaco, Ansiedad, Abstinencia, Opiáceos, Naltrexona, Efectos, Tratamiento médico, Evaluación, Resultados, Estudio comparativo
Antzeko izenburuak: The impact of the opioid antagonist naloxone on experimentally induced craving in nicotine-dependent individuals
- NEUROBIOLOGICAL SUBSTRATES OF CUE-ELICITED CRAVING AND ANHEDONIA IN RECENTLY ABSTINENT OPIOID-DEPENDENT MALES
- PUBLIC POLICY STATEMENT ON OPIOID ANTAGONIST AGENT DETOXIFICATION UNDER SEDATION OR ANESTHESIA (OADUSA)
- CLINICAL EXPERIENCE WITH ANTAGONIST-INDUCED OPIATE WITHDRAWAL UNDER ANAESTHESIA
- MAINTENANCE TREATMENT WITH DEPOT OPIOID ANTAGONISTS IN SUBCUTANEOUS IMPLANTS. AN ALTERNATIVE IN THE TREATMENT OF OPIOID DEPENDENCE
- EXPERIMENTALLY-INDUCED SPONTANEOUS OPIATE WITHDRAWAL: RELATIONSHIP TO CIGARETTE CRAVING AND EXPIRED AIR CARBON MONOXIDE
- CLONIDINE AND OPIATE RECEPTOR ANTAGONISTS IN THE TREATMENT OF HEROIN ADDICTION